
Semaglutide, tirzepatide, or sleeve gastrectomy: what 1-year data actually show for type 2 diabetes and obesity
A 2025 retrospective cohort study compared all three options head-to-head. Here is what the numbers mean for you and how we think about the choice.
Read Article










